Skip to menu Skip to content Skip to footer

Frailty-stratified randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma - the FRAIL-M study (MRFF LSCD Grant Administered by Monash) (2019-2023)

Experts

Professor Ruth Hubbard

Masonic Chair of Geriatric Medicine
Centre for Health Services Research
Faculty of Medicine
Ruth Hubbard
Ruth Hubbard